{
    "info": {
        "nct_id": "NCT06465953",
        "official_title": "A Phase 3, Multicenter, Open Label, Randomized, Non-comparative Two-arm Study of Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Adult Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an Isocitrate Dehydrogenase-1 (IDH1) Mutation (PyramIDH Study)",
        "inclusion_criteria": "* Diagnosis of HMA naive IDH1 R132 mutated MDS defined according to WHO criteria (5th edition):\n* Moderate high, high and very high-risk MDS per IPSS-M score will be eligible regardless of blood counts and with blast counts 0-19%.\n* Low and moderate low-risk MDS per IPSS-M score must:\n* Have cytopenias related to MDS, defined as: <100 platelets/microliter, or absolute neutrophil count (ANC) <1000/mm3, or hemoglobin <10g/dL AND\n* Have a blast count between 5-19% AND\n* Be eligible for HMA therapy (very low risk participants are to be excluded)\n* Locally or centrally confirmed IDH1 R132 C/G/H/L/S mutation\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Received prior anticancer/disease modifying treatment for MDS (including HMA's, cytotoxic chemotherapy, investigational agents, bcl-2 inhibitor based-regimens, hematopoietic stem cell transplant (HSCT), IDH1 inhibitors). For LR-MDS patients, prior treatment with growth factors, luspatercept, lenalidomide, and imetelstat are allowed.\n* >20% blasts by morphology or immunohistochemistry on screening bone marrow aspirate/biopsy",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "identified_line": {
                "line": "* Have a blast count between 5-19% AND",
                "criterions": [
                    {
                        "exact_snippets": "blast count between 5-19%",
                        "criterion": "blast count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 5,
                                        "unit": "%"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 19,
                                        "unit": "%"
                                    }
                                ]
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "blast count between 5-19%",
                        "criterion": "blast count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 5,
                                        "unit": "%"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 19,
                                        "unit": "%"
                                    }
                                ]
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Healthy volunteers allowed",
                "criterions": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Be eligible for HMA therapy (very low risk participants are to be excluded)",
                "criterions": [
                    {
                        "exact_snippets": "Be eligible for HMA therapy",
                        "criterion": "eligibility for HMA therapy",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "very low risk participants are to be excluded",
                        "criterion": "risk category",
                        "requirement": {
                            "requirement_type": "category",
                            "expected_value": "not very low risk"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Be eligible for HMA therapy",
                        "criterion": "eligibility for HMA therapy",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "very low risk participants are to be excluded",
                        "criterion": "risk category",
                        "requirement": {
                            "requirement_type": "category",
                            "expected_value": "not very low risk"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Have cytopenias related to MDS, defined as: <100 platelets/microliter, or absolute neutrophil count (ANC) <1000/mm3, or hemoglobin <10g/dL AND",
                "criterions": [
                    {
                        "exact_snippets": "cytopenias related to MDS",
                        "criterion": "cytopenias related to MDS",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "<100 platelets/microliter",
                        "criterion": "platelet count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 100,
                                "unit": "platelets/microliter"
                            }
                        }
                    },
                    {
                        "exact_snippets": "absolute neutrophil count (ANC) <1000/mm3",
                        "criterion": "absolute neutrophil count (ANC)",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 1000,
                                "unit": "mm3"
                            }
                        }
                    },
                    {
                        "exact_snippets": "hemoglobin <10g/dL",
                        "criterion": "hemoglobin",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 10,
                                "unit": "g/dL"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "cytopenias related to MDS",
                        "criterion": "cytopenias related to MDS",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "or_criteria": [
                            {
                                "exact_snippets": "<100 platelets/microliter",
                                "criterion": "platelet count",
                                "requirement": {
                                    "requirement_type": "quantity",
                                    "expected_value": {
                                        "operator": "<",
                                        "value": 100,
                                        "unit": "platelets/microliter"
                                    }
                                }
                            },
                            {
                                "exact_snippets": "absolute neutrophil count (ANC) <1000/mm3",
                                "criterion": "absolute neutrophil count (ANC)",
                                "requirement": {
                                    "requirement_type": "quantity",
                                    "expected_value": {
                                        "operator": "<",
                                        "value": 1000,
                                        "unit": "mm3"
                                    }
                                }
                            },
                            {
                                "exact_snippets": "hemoglobin <10g/dL",
                                "criterion": "hemoglobin",
                                "requirement": {
                                    "requirement_type": "quantity",
                                    "expected_value": {
                                        "operator": "<",
                                        "value": 10,
                                        "unit": "g/dL"
                                    }
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Must have minimum age of 18 Years",
                "criterions": [
                    {
                        "exact_snippets": "minimum age of 18 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "minimum age of 18 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Diagnosis of HMA naive IDH1 R132 mutated MDS defined according to WHO criteria (5th edition):",
                "criterions": [
                    {
                        "exact_snippets": "Diagnosis of HMA naive IDH1 R132 mutated MDS defined according to WHO criteria (5th edition)",
                        "criterion": "myelodysplastic syndrome (MDS)",
                        "requirement": {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Diagnosis of HMA naive IDH1 R132 mutated MDS defined according to WHO criteria (5th edition)",
                        "criterion": "myelodysplastic syndrome (MDS)",
                        "requirement": {
                            "requirement_type": "definition standard",
                            "expected_value": "WHO criteria (5th edition)"
                        }
                    },
                    {
                        "exact_snippets": "HMA naive",
                        "criterion": "hypomethylating agent (HMA) treatment",
                        "requirement": {
                            "requirement_type": "prior exposure",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "IDH1 R132 mutated",
                        "criterion": "IDH1 R132 mutation",
                        "requirement": {
                            "requirement_type": "mutation status",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Diagnosis of HMA naive IDH1 R132 mutated MDS defined according to WHO criteria (5th edition)",
                        "criterion": "myelodysplastic syndrome (MDS)",
                        "requirement": {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Diagnosis of HMA naive IDH1 R132 mutated MDS defined according to WHO criteria (5th edition)",
                        "criterion": "myelodysplastic syndrome (MDS)",
                        "requirement": {
                            "requirement_type": "definition standard",
                            "expected_value": "WHO criteria (5th edition)"
                        }
                    },
                    {
                        "exact_snippets": "HMA naive",
                        "criterion": "hypomethylating agent (HMA) treatment",
                        "requirement": {
                            "requirement_type": "prior exposure",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "IDH1 R132 mutated",
                        "criterion": "IDH1 R132 mutation",
                        "requirement": {
                            "requirement_type": "mutation status",
                            "expected_value": true
                        }
                    }
                ]
            }
        }
    ],
    "exclusion_lines": [],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "identified_line": {
                "line": "* Locally or centrally confirmed IDH1 R132 C/G/H/L/S mutation",
                "criterions": [
                    {
                        "exact_snippets": "Locally or centrally confirmed IDH1 R132 C/G/H/L/S mutation",
                        "criterion": "IDH1 R132 mutation",
                        "requirement": {
                            "requirement_type": "mutation subtype",
                            "expected_value": [
                                "C",
                                "G",
                                "H",
                                "L",
                                "S"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "Locally or centrally confirmed IDH1 R132 C/G/H/L/S mutation",
                        "criterion": "IDH1 R132 mutation",
                        "requirement": {
                            "requirement_type": "confirmation location",
                            "expected_value": [
                                "local",
                                "central"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "* Low and moderate low-risk MDS per IPSS-M score must:",
                "criterions": [
                    {
                        "exact_snippets": "Low and moderate low-risk MDS per IPSS-M score",
                        "criterion": "MDS risk category (per IPSS-M score)",
                        "requirement": {
                            "requirement_type": "category",
                            "expected_value": [
                                "low-risk",
                                "moderate low-risk"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "* Moderate high, high and very high-risk MDS per IPSS-M score will be eligible regardless of blood counts and with blast counts 0-19%.",
                "criterions": [
                    {
                        "exact_snippets": "Moderate high, high and very high-risk MDS per IPSS-M score",
                        "criterion": "MDS risk category (IPSS-M score)",
                        "requirement": {
                            "requirement_type": "category",
                            "expected_value": [
                                "moderate high",
                                "high",
                                "very high"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "blast counts 0-19%",
                        "criterion": "blast count",
                        "requirement": {
                            "requirement_type": "percentage",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "%"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 19,
                                        "unit": "%"
                                    }
                                ]
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        }
    ],
    "failed_exclusion": [
        {
            "identified_line": {
                "line": "* >20% blasts by morphology or immunohistochemistry on screening bone marrow aspirate/biopsy",
                "criterions": [
                    {
                        "exact_snippets": ">20% blasts by morphology ... on screening bone marrow aspirate/biopsy",
                        "criterion": "blasts in bone marrow",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 20,
                                "unit": "%"
                            }
                        }
                    },
                    {
                        "exact_snippets": ">20% blasts by morphology ... on screening bone marrow aspirate/biopsy",
                        "criterion": "blasts in bone marrow",
                        "requirement": {
                            "requirement_type": "detection_method",
                            "expected_value": [
                                "morphology",
                                "immunohistochemistry"
                            ]
                        }
                    },
                    {
                        "exact_snippets": ">20% blasts by morphology ... on screening bone marrow aspirate/biopsy",
                        "criterion": "blasts in bone marrow",
                        "requirement": {
                            "requirement_type": "specimen_type",
                            "expected_value": [
                                "bone marrow aspirate",
                                "bone marrow biopsy"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "* Received prior anticancer/disease modifying treatment for MDS (including HMA's, cytotoxic chemotherapy, investigational agents, bcl-2 inhibitor based-regimens, hematopoietic stem cell transplant (HSCT), IDH1 inhibitors). For LR-MDS patients, prior treatment with growth factors, luspatercept, lenalidomide, and imetelstat are allowed.",
                "criterions": [
                    {
                        "exact_snippets": "Received prior anticancer/disease modifying treatment for MDS (including HMA's, cytotoxic chemotherapy, investigational agents, bcl-2 inhibitor based-regimens, hematopoietic stem cell transplant (HSCT), IDH1 inhibitors)",
                        "criterion": "prior anticancer/disease modifying treatment for MDS",
                        "requirement": {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Received prior anticancer/disease modifying treatment for MDS (including HMA's, cytotoxic chemotherapy, investigational agents, bcl-2 inhibitor based-regimens, hematopoietic stem cell transplant (HSCT), IDH1 inhibitors)",
                        "criterion": "prior anticancer/disease modifying treatment for MDS",
                        "requirement": {
                            "requirement_type": "treatment types",
                            "expected_value": [
                                "HMA's",
                                "cytotoxic chemotherapy",
                                "investigational agents",
                                "bcl-2 inhibitor based-regimens",
                                "hematopoietic stem cell transplant (HSCT)",
                                "IDH1 inhibitors"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        }
    ],
    "failed_miscellaneous": []
}